Soriot's Future And MYSTIC Data To Dominate AstraZeneca's 2Q

 
• By Lucie Ellis-Taitt
  
Sphere
AstraZeneca’s future in oncology hangs on MYSTIC; but is Soriot in or out? • Source: Shutterstock

More from Strategy

More from Business